LFVN Lifevantage

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against LifeVantage Corporation and Reminds Investors with Losses to Contact the Firm

Khang & Khang LLP (the “Firm”) announces a class action lawsuit has been filed against LifeVantage Corporation (“LifeVantage” or the “Company”) (Nasdaq: LFVN). Investors who purchased or otherwise acquired shares between November 4, 2015 and September 13, 2016 inclusive (the “Class Period”), are encouraged to contact the Firm prior to the November 14, 2016 lead plaintiff motion deadline.

If you purchased shares of LifeVantage during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at [email protected].

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

The complaint alleges that during the Class Period, LifeVantage made false and/or misleading statements and/or failed to disclose: that the Company lacked effective internal financial controls; that the Company improperly accounted for sales in certain international markets, along with associated revenue and income tax accruals; and that as a result of the above, LifeVantage’s public statements were materially false and misleading at all relevant times. On September 13, 2016, the Company announced that it would delay the release of its fourth quarter and fiscal year 2016 financial results. The reason for the delay was LifeVantage to carry out an internal review of sales into certain international markets and the revenue and income tax associated with those sales. The Company stated that it is unable to estimate the impact of the review to net revenue, tax expense, net income or other aspects of its financial statements for the fiscal year ended June 30, 2016 or any potential prior periods. When this news was announced, shares of LifeVantage decreased in value, causing investors harm.

If you wish to learn more about this lawsuit, or if you have questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at [email protected].

This press release may constitute Attorney Advertising in some jurisdictions.

EN
16/09/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Lifevantage

 PRESS RELEASE

LifeVantage Declares Quarterly Dividend

LifeVantage Declares Quarterly Dividend SALT LAKE CITY, Feb. 04, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company’s Board of Directors has approved a quarterly cash dividend of $0.045 per share of common stock, which will be paid March 16, 2026 to all stockholders of record at the close of business on March 2, 2026. About LifeVantage Corporation LifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a pioneer...

 PRESS RELEASE

LifeVantage Announces Planned Retirement of Steve Fife and CEO Success...

LifeVantage Announces Planned Retirement of Steve Fife and CEO Succession Plan SALT LAKE CITY, Feb. 04, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health at the cellular level, today announced that after nine years at LifeVantage, Steve Fife, President, Chief Executive Officer and a member of the Board of Directors (the “Board”), has decided to retire in April, 2026. Fife will continue in his role as President and Chief Executive Officer during the transition period to ensure business continuity through his re...

 PRESS RELEASE

LifeVantage Announces Financial Results for the Second Quarter of Fisc...

LifeVantage Announces Financial Results for the Second Quarter of Fiscal 2026 Announces New $60 Million Share Repurchase Authorization SALT LAKE CITY, Feb. 04, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its second fiscal quarter ended December 31, 2025. Second Quarter Fiscal 2026 Summary*: Revenue was $48.9 million, a decrease of 27.8% from the prior year period. Revenue was up 2.9% sequentially from the fir...

 PRESS RELEASE

LifeVantage to Announce Second Quarter Fiscal Year 2026 Results on Feb...

LifeVantage to Announce Second Quarter Fiscal Year 2026 Results on February 4, 2026 SALT LAKE CITY, Jan. 21, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its second quarter ended December 31, 2025, after the stock market closes on Wednesday, February 4, 2026. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day. Investors inter...

 PRESS RELEASE

LifeVantage Kicked Off 2026 With Global Kickoff, a Virtual Event Showc...

LifeVantage Kicked Off 2026 With Global Kickoff, a Virtual Event Showcasing Innovation and Integration The company shared momentum following the LoveBiome integration and unveiled its Daily Activation App SALT LAKE CITY, Jan. 12, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health at the cellular level, announced the successful conclusion of its Global Kickoff, a virtual company-wide event that united LifeVantage Consultants worldwide and set the tone for a new year of growth, innovation, and momentum. Breakth...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch